Livpalm S Softgel Capsule is a pharmaceutical formulation combining L-Ornithine L-Aspartate (250 mg) and Silymarin (140 mg), designed to support liver health and function. L-Ornithine L-Aspartate is an amino acid compound that facilitates ammonia detoxification by enhancing the urea cycle, thereby reducing blood ammonia levels commonly elevated in hepatic encephalopathy and other liver dysfunctions. Silymarin, a flavonoid complex extracted from the milk thistle plant, exhibits potent antioxidant, anti-inflammatory, and hepatoprotective properties. It stabilizes hepatocyte membranes, promotes regeneration of liver tissue, and protects against toxin-induced liver damage. The synergistic action of these components aids in improving liver enzyme profiles, enhancing detoxification processes, and mitigating oxidative stress. Livpalm S is indicated for adjunctive therapy in chronic liver diseases such as cirrhosis, hepatitis, and fatty liver, as well as for the management of hepatic encephalopathy. It is generally well tolerated, with minimal adverse effects reported. The softgel formulation ensures optimal bioavailability and ease of administration. Livpalm S Softgel Capsule should be used under medical supervision, with dosage adjustments based on clinical response and liver function status. It is not recommended for use in patients with known hypersensitivity to its components.